# Efficacy Study of Hypothermia Plus Magnesium Sulphate(MgSO4) in the Management of Term and Near Term Babies With Hypoxic Ischemic Encephalopathy

> **NCT01646619** · PHASE3 · UNKNOWN · sponsor: **Sajjad Rahman** · enrollment: 300 (estimated)

## Conditions studied

- Severe Hypoxic Ischemic Encephalopathy
- Moderate Hypoxic Ischemic Encephalopathy

## Interventions

- **DRUG:** Magnesium Sulphate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01646619
- **Lead sponsor:** Sajjad Rahman
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-05
- **Primary completion:** 2013-12
- **Final completion:** 2014-06
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2013-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01646619

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01646619, "Efficacy Study of Hypothermia Plus Magnesium Sulphate(MgSO4) in the Management of Term and Near Term Babies With Hypoxic Ischemic Encephalopathy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01646619. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*